We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Updated RA Drug Draft Guidance Nixes Placebos in Longer Trials
Updated RA Drug Draft Guidance Nixes Placebos in Longer Trials
June 19, 2013
Placebo-controlled trials to evaluate long-term rheumatoid arthritis (RA) drugs are no longer feasible, according to an updated draft guidance issued by the FDA.